William Sosbe died in June with a Dexcom G7 still fixed to his arm. His sisters say the device had been dropping signal for months and then went silent two days before he died.
Our story on how $DXCM, one of America’s largest medical device manufacturers, put millions at risk.
The G7 arrived with a promise that sounded simple. No more constant fingersticks, just a steady stream of glucose data and timely alarms. Doctors recommended it, ads celebrated it, and patients trusted it.
Our reporting found a different reality. ICU admissions, drivers fainting, children in emergency rooms, and families alleging deaths tied to inaccurate readings and failed alerts. Users describe months of false highs and lows, and sensor failures, that led to dangerous dosing.